Fermion Oy – FDA 483
An FDA inspection of Fermion Oy, Espoo Plant, a contract testing laboratory, revealed significant data integrity issues related to LC-MS equipment, including the ability to delete data without audit trail capture, unreviewed electronic data, and inadequate data backup. The inspection also cited a lack of change control for work instructions and an ineffective CAPA for previously identified data integrity problems. These findings indicate serious deficiencies in the firm's quality management system.
- Company
- Fermion Oy
- Product type
- drugs
ID · e9359956-71c2-4266-8e7f-c1ef3c6b675a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.